|Articles|March 24, 2016
Determination of Beta-Blockers in Urine Using SFC/MS
This Application Note demonstrates the separation and quantification of beta-blockers, listed as prohibited substances by the World Anti-Doping Agency, in urine using the Agilent 1260 Infinity Analytical SFC System.
Trending on LCGC International
1
HPLC, PTR-ToF-MS Enable AI Grading of White Tea
2
Py-GC–MS Reveals Microplastics in Playgrounds
3
Analytical Procedure Lifecycle Approaches in Accordance With ICH Q14 and ICH Q2(R2): Opportunity Knocks or Just Another Challenge and Headache? (Part 2)
4
LC-MS/MS Links Vitamin D Levels to Sleep Timing
5